Literature DB >> 27335697

Comparison of stem cell therapies for acute kidney injury.

Carol J Barnes1, Casey T Distaso1, Kristin M Spitz1, Valerie A Verdun1, Aviad Haramati2.   

Abstract

Acute kidney injury (AKI) is the rapid onset of decreased kidney function that ultimately increases mortality and morbidity. Stem cell research is a promising avenue for curative and preventative therapies of kidney injury, however, there are many types of stem cells under investigation. Currently there is no research to compare the value of one stem cell method over another. Induced pluripotent stem cells (iPSCs) and spermatogonial stem cells (SSCs) have been shown to differentiate into renal cells, though further clinical research is needed to fully explore potential therapeutic strategies. Mesenchymal stem cells (MSCs) have long been investigated in the preclinical setting and have recently been successful in Phase I clinical trials. MSCs may represent a promising new therapeutic approach to treat AKI as they demonstrate renoprotective effects post-injury via the secretion of promitotic, anti-apoptotic, anti-inflammatory, and immunomodulatory factors. Given the most current research, MSCs appear to offer a promising course of treatment for AKI.

Entities:  

Keywords:  AKI; Induced pluripotent stem cells; acute kidney injury; mesenchymal stem cells; spermatogonial stem cells; treatment

Year:  2016        PMID： 27335697      PMCID： PMC4913292     

Source DB:  PubMed          Journal:  Am J Stem Cells        ISSN： 2160-4150


  31 in total

Review 1.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

2.  Pluripotency of spermatogonial stem cells from adult mouse testis.

Authors:  Kaomei Guan; Karim Nayernia; Lars S Maier; Stefan Wagner; Ralf Dressel; Jae Ho Lee; Jessica Nolte; Frieder Wolf; Manyu Li; Wolfgang Engel; Gerd Hasenfuss
Journal:  Nature       Date:  2006-03-24       Impact factor: 49.962

3.  Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats.

Authors:  Pei-Ying Lee; Yueh Chien; Guang-Yuh Chiou; Chi-Hung Lin; Chih-Hwa Chiou; Der-Cherng Tarng
Journal:  Cell Transplant       Date:  2012-04-10       Impact factor: 4.064

Review 4.  Mesenchymal stem cells and kidney repair.

Authors:  Marina Morigi; Ariela Benigni
Journal:  Nephrol Dial Transplant       Date:  2012-12-20       Impact factor: 5.992

5.  Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.

Authors:  S M Devine; A M Bartholomew; N Mahmud; M Nelson; S Patil; W Hardy; C Sturgeon; T Hewett; T Chung; W Stock; D Sher; S Weissman; K Ferrer; J Mosca; R Deans; A Moseley; R Hoffman
Journal:  Exp Hematol       Date:  2001-02       Impact factor: 3.084

6.  Insulin-like growth factor-1 sustains stem cell mediated renal repair.

Authors:  Barbara Imberti; Marina Morigi; Susanna Tomasoni; Cinzia Rota; Daniela Corna; Lorena Longaretti; Daniela Rottoli; Federica Valsecchi; Ariela Benigni; Jun Wang; Mauro Abbate; Carla Zoja; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

Review 7.  Paracrine mechanisms in adult stem cell signaling and therapy.

Authors:  Massimiliano Gnecchi; Zhiping Zhang; Aiguo Ni; Victor J Dzau
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

8.  Renal cells from spermatogonial germline stem cells protect against kidney injury.

Authors:  Letizia De Chiara; Sharmila Fagoonee; Andrea Ranghino; Stefania Bruno; Giovanni Camussi; Emanuela Tolosano; Lorenzo Silengo; Fiorella Altruda
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

9.  Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells.

Authors:  Nina Kossack; Juanito Meneses; Shai Shefi; Ha Nam Nguyen; Shawn Chavez; Cory Nicholas; Joerg Gromoll; Paul J Turek; Renee A Reijo-Pera
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

Review 10.  Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials.

Authors:  Christof Westenfelder; Florian E Togel
Journal:  Kidney Int Suppl (2011)       Date:  2011-09
View more
  16 in total

1.  Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery.

Authors:  Madhav Swaminathan; Mark Stafford-Smith; Glenn M Chertow; David G Warnock; Viken Paragamian; Robert M Brenner; François Lellouche; Alison Fox-Robichaud; Mohamed G Atta; Spencer Melby; Ravindra L Mehta; Ron Wald; Subodh Verma; C David Mazer
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

Review 2.  The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation.

Authors:  Sergio Dellepiane; Davide Medica; Alessandro Domenico Quercia; Vincenzo Cantaluppi
Journal:  J Nephrol       Date:  2017-03-21       Impact factor: 3.902

3.  Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.

Authors:  Mai Barakat; Abdelaziz M Hussein; Mohamed F Salama; Amira Awadalla; Nashwa Barakat; Mohamed Serria; Mohamed El-Shafey; Mohamed El-Sherbiny; Mohamed A El Adl
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

4.  Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4.

Authors:  Amruta Barhanpurkar-Naik; Suhas T Mhaske; Satish T Pote; Kanupriya Singh; Mohan R Wani
Journal:  Stem Cell Res Ther       Date:  2017-07-14       Impact factor: 6.832

Review 5.  Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group.

Authors:  Mitra K Nadim; Lui G Forni; Azra Bihorac; Charles Hobson; Jay L Koyner; Andrew Shaw; George J Arnaoutakis; Xiaoqiang Ding; Daniel T Engelman; Hrvoje Gasparovic; Vladimir Gasparovic; Charles A Herzog; Kianoush Kashani; Nevin Katz; Kathleen D Liu; Ravindra L Mehta; Marlies Ostermann; Neesh Pannu; Peter Pickkers; Susanna Price; Zaccaria Ricci; Jeffrey B Rich; Lokeswara R Sajja; Fred A Weaver; Alexander Zarbock; Claudio Ronco; John A Kellum
Journal:  J Am Heart Assoc       Date:  2018-06-01       Impact factor: 5.501

6.  Controlled Delivery of Stem Cell-Derived Trophic Factors Accelerates Kidney Repair After Renal Ischemia-Reperfusion Injury in Rats.

Authors:  Hyung Eun Yim; Doo Sang Kim; Hyun Chul Chung; Brian Shing; Kyung Hyun Moon; Sunil K George; Michael W Kim; Zachary Atala; Ji Hyun Kim; In Kap Ko; James J Yoo
Journal:  Stem Cells Transl Med       Date:  2019-05-30       Impact factor: 6.940

7.  Modulation of Renal Parenchyma in Response to Allogeneic Adipose-Derived Mesenchymal Stem Cells Transplantation in Acute Kidney Injury.

Authors:  Sumreen Begum; Nazia Ahmed; Muhammed Mubarak; Syeda Mamoona Mateen; Nida Khalid; Syed Adibul Hasan Rizvi
Journal:  Int J Stem Cells       Date:  2019-03-30       Impact factor: 2.500

Review 8.  Tissue Engineering and Stem Cell Therapy in Pediatric Urology.

Authors:  Shilpa Sharma; Devendra K Gupta
Journal:  J Indian Assoc Pediatr Surg       Date:  2019 Oct-Dec

9.  Intracellular Reactive Oxygen Species Mediate the Therapeutic Effect of Induced Pluripotent Stem Cells for Acute Kidney Injury.

Authors:  Shun Wang; Xiaoyu Tian; Yijun Li; Rong Xue; Haochen Guan; Meng Lu; Huijun Xu; Zhibin Ye; Sifeng Chen; Meng Xiang
Journal:  Oxid Med Cell Longev       Date:  2020-03-26       Impact factor: 6.543

10.  The effect of adipose-derived mesenchymal stem cells on renal function and histopathology in a rat model of ischemia-reperfusion induced acute kidney injury.

Authors:  Saeed Changizi-Ashtiyani; Leila Hafazeh; Faezeh Ghasemi; Houshang Najafi; Saeed Babaei; Farideh JalallyMashayekhi; Seyed Javad Hoseini; Bahar Bastani
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.